Latest filing published 01 Mar 2022 for Thermo Fisher Scientific INC., €924k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mark Stevenson: trading record in brief
This profile gathers the share dealings of Mark Stevenson across 3 companies, led by Thermo Fisher Scientific Inc., Invitrogen Corp and Applera Corp. The record holds 172 filings, for trades running from 16 August 2007 to 25 February 2022.
The open-market side counts 1 purchase for €126k alongside 62 sales for €116.2M. Taken together, the sales exceed the purchases by €116.1M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 70 share grants and 26 option exercises.
The record was last updated on 1 March 2022 with a share grant (€924k) in Thermo Fisher Scientific Inc. The latest purchase dates back some time: it was published 5,555 days ago, on 24 August 2011. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mark Stevenson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,880 shares@ US$549.8310.2% of flowCommon StockSEC:0001127602-22-007461:0
- 1,035 shares@ US$528.580.3% of flowCommon StockSEC:0001127602-22-006845:1
- 1,200 shares@ US$528.580.3% of flowCommon StockSEC:0001127602-22-006845:2
- 7,000 shares0Common StockSEC:0001127602-22-006845:0
- 12,375 shares@ US$157.681.0% of flowCommon StockSEC:0001127602-21-030245:1
- 1,408 shares@ US$626.540.5% of flowCommon StockSEC:0001127602-21-030245:2
- 1,364 shares@ US$627.460.5% of flowCommon StockSEC:0001127602-21-030245:3
- 2,350 shares@ US$628.500.8% of flowCommon StockSEC:0001127602-21-030245:4
- 2,393 shares@ US$629.550.8% of flowCommon StockSEC:0001127602-21-030245:5
- 4,731 shares@ US$631.801.6% of flowCommon StockSEC:0001127602-21-030245:7
- 4,317 shares@ US$632.791.5% of flowCommon StockSEC:0001127602-21-030245:8
- 1,738 shares@ US$633.670.6% of flowCommon StockSEC:0001127602-21-030245:9
- 1,204 shares@ US$634.820.4% of flowCommon StockSEC:0001127602-21-030245:10
- 3,354 shares@ US$635.961.1% of flowCommon StockSEC:0001127602-21-030245:11
- 1,307 shares@ US$636.760.4% of flowCommon StockSEC:0001127602-21-030245:12
- 2,759 shares@ US$630.700.9% of flowCommon StockSEC:0001127602-21-030245:6
- 14,550 shares@ US$190.5927.1% of flowCommon StockSEC:0001127602-21-030245:0
- 2,000 shares@ US$629.710.7% of flowCommon StockSEC:0001127602-21-028299:3
- 4,141 shares@ US$630.691.4% of flowCommon StockSEC:0001127602-21-028299:4
- 3,769 shares@ US$631.721.2% of flowCommon StockSEC:0001127602-21-028299:5
- 2,367 shares@ US$632.700.8% of flowCommon StockSEC:0001127602-21-028299:6
- 6,169 shares@ US$633.922.0% of flowCommon StockSEC:0001127602-21-028299:7
- 5,209 shares@ US$634.711.7% of flowCommon StockSEC:0001127602-21-028299:8
- 900 shares@ US$635.780.3% of flowCommon StockSEC:0001127602-21-028299:9
- 800 shares@ US$636.820.3% of flowCommon StockSEC:0001127602-21-028299:10
25 of 172 declarations
